aminocaproic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McIntyre, EA | 1 |
Halse, R | 1 |
Yeaman, SJ | 1 |
Walker, M | 1 |
Doyle, ME | 1 |
Greig, NH | 1 |
Holloway, HW | 1 |
Betkey, JA | 1 |
Bernier, M | 1 |
Egan, JM | 1 |
2 other studies available for aminocaproic acid and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide riboside-stimulated, glucose uptake.
Topics: Aged; Aminocaproic Acid; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glucose; Glycogen; Glyc | 2004 |
Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.
Topics: Amino Acid Sequence; Aminocaproic Acid; Animals; Cell Line; Diabetes Mellitus, Type 2; Glucagon; Glu | 2001 |